Literature DB >> 3367180

Evaluation of diagnostic tests with multiple diagnostic categories.

N J Birkett1.   

Abstract

The evaluation of diagnostic tests attempts to obtain one or more statistical parameters which can indicate the intrinsic diagnostic utility of a test. Sensitivity, specificity and predictive value are not appropriate for this use. The likelihood ratio has been proposed as a useful measure when using a test to diagnose one of two disease states (e.g. disease present or absent). In this paper, we generalize the likelihood ratio concept to a situation in which the goal is to diagnose one of several non-overlapping disease states. A formula is derived to determine the post-test probability of a specific disease state. The post-test odds are shown to be related to the pre-test odds of a disease and to the usual likelihood ratios derived from considering the diagnosis between the target diagnosis and each alternate in turn. Hence, likelihood ratios derived from comparing pairs of diseases can be used to determine test utility in a multiple disease diagnostic situation.

Mesh:

Year:  1988        PMID: 3367180     DOI: 10.1016/0895-4356(88)90051-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Urinary neopterin concentrations and T-cell subset data in HIV-1 infection.

Authors:  G Reibnegger; D Fuchs; J J Goedert; A Hausen; A Krämer; E R Werner; G Werner-Felmayer; M P Dierich; H Wachter
Journal:  Klin Wochenschr       Date:  1990-01-04

2.  A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

Authors:  P R Talbot; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

3.  Optimum binary cut-off threshold of a diagnostic test: comparison of different methods using Monte Carlo technique.

Authors:  Gilbert Reibnegger; Walter Schrabmair
Journal:  BMC Med Inform Decis Mak       Date:  2014-11-25       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.